TerrAscend Corp TSND
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
TerrAscend Strengthens Leadership Position in New Jersey with Closing of Aunt Mary’s Transaction
-
TerrAscend to Participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference
-
TerrAscend Announces Results of Special Meeting of Shareholders
-
TerrAscend Announces Renewal and Replenishment of $10 Million Share Repurchase Program
-
TerrAscend Reports Second Quarter 2026 Financial Results
Trading Information
- Previous Close Price
- CA$0.70
- Day Range
- CA$0.67–0.68
- 52-Week Range
- CA$0.53–2.00
- Bid/Ask
- CA$0.66 / CA$0.71
- Shares Outstanding
- 309.18M
- Market Cap
- CA$207.15M
- Volume/Avg
- 128,274 / 193,605
Key Statistics
- Price/Earnings (Normalized)
- 5.35
- Price/Sales
- 0.57
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 0.28%
Company Profile
TerrAscend Corp is a company focused on creating and delivering cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. In addition, the firm operates in California, Maryland, New Jersey, and Pennsylvania, with retail operations in Ohio and Canada. It operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. The firm has one operating segment, being the cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States. The company generates key revenue from the United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,038
- Website
- https://www.terrascend.com
Valuation
|
Metric
|
TSND
|
|---|---|
Price/Earnings (Normalized) | 5.35 |
Price/Book Value | 1.86 |
Price/Sales | 0.57 |
Price/Cash Flow | 16.66 |
Price/Earnings
TSND
Financial Strength
|
Metric
|
TSND
|
|---|---|
Quick Ratio | 0.94 |
Current Ratio | 1.83 |
Interest Coverage | 1.10 |
Quick Ratio
TSND
Profitability
|
Metric
|
TSND
|
|---|---|
Return on Assets (Normalized) | −3.54% |
Return on Equity (Normalized) | −20.67% |
Return on Invested Capital (Normalized) | 3.62% |
Return on Assets
TSND
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|Mgmn>&!Z | LOCK|&<$mZ | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|@DZJP@< | LOCK|^%yy< | $48B | |||
| Haleon PLC ADR
HLN
| LOCK|@t<&@f | LOCK|&B | $44B | |||
| Zoetis Inc Class A
ZTS
| LOCK|V>F^Z!bN | LOCK|@N | $33B | |||
| Viatris Inc
VTRS
| LOCK|B!<hZT | LOCK|SP | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|@p | LOCK|k#R | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|Yn$HNgr | LOCK|@#r | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|^KW<&JV | LOCK|JM | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|L$Y%w^ | LOCK|M!#v | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|#Wk>l& | LOCK|<m | $2B |
United States